Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-07

FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's supplemental application for ropinirole, a generic version used to treat Parkinson's disease and restless legs sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole (ropinirole)

Snippet

SUPPL AP for ROPINIROLE (ROPINIROLE)